FENC
FENC
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
1
$105K
Insider Sales
37
$13.72M
Total Volume
$13.83M
77 transactions
Net Activity
$13.62M
Net selling
Sentiment Rating
Neutral / BalancedCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Heavy distribution: sales represent 99% of total transaction value.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
S - Sale+OE Insiders
$225.00M total
Southpoint Capital Advisors LP
10%
$10.34M total
Raykov Rosty
Former Director
$1.82M total
Andrade Robert
CFO
$884K total
Brughera Marco Maria
Dir
$400K total
Quick Actions
FENC has an insider buy conviction of 1%, compared to the Unknown sector buy average of 6%. FENC ranks #428 in insider activity out of 570 tracked companies in its industry.
Over the last 90 days, corporate insiders at FENC (FENC) engaged in a total of 77 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 37 were sales. The total volume of insider trading reached $13.83M.
The net insider activity for FENC shows a net selling bias of $13.62M. This activity represents a 1% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 15.0K shares valued at $225.00M on May 16, 2025.
Fennec Pharmaceuticals (FENC) Stock Sees Fair Value Lift As Analysts Raise PEDMARK Views
FENC Forecast — Price Target — Prediction for 2027
Fennec Pharmaceuticals (NasdaqCM:FENC) Stock Forecast & Analyst Predictions
Fennec: The Turnaround Is Real, But The Stock Prices In Perfection (Downgrade)
FENNEC PHARMACEUTICALS ($FENC) Releases Q3 2026 Earnings
An 8:30 a.m. call will cover Fennec's quarterly results on Nov. 12.
FAQs About FENC Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for FENC.